Mechanism of Action and Structural Requirements of Constrained Peptide Inhibitors of RGS Proteins
Open Access
- 18 April 2006
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 67 (4) , 266-274
Abstract
Regulators of G‐protein signaling (RGS) accelerate guanine triphosphate hydrolysis by Gα‐subunits and profoundly inhibit signaling by G protein‐coupled receptors. The distinct expression patterns and pathophysiologic regulation of RGS proteins suggest that inhibitors may have therapeutic potential. We previously reported the design of a constrained peptide inhibitor of RGS4 (1:Ac‐Val‐Lys‐[Cys‐Thr‐Gly‐Ile‐Cys]‐Glu‐NH2, S‐S) based on the structure of the Gαi switch 1 region but its mechanism of action was not established. In the present study, we show that 1 inhibits RGS4 by mimicking and competing for binding with the switch 1 region of Gαi and that peptide 1 shows selectivity for RGS4 and RGS8 versus RGS7. Structure–activity relationships of analogs related to 1 are described that illustrate key features for RGS inhibition. Finally, we demonstrate activity of the methylene dithioether‐bridged peptide inhibitor, 2, to modulate muscarinic receptor‐regulated potassium currents in atrial myocytes. These data support the proposed mechanism of action of peptide RGS inhibitors, demonstrate their action in native cells, and provide a starting point for the design of RGS inhibitor drugs.Keywords
This publication has 30 references indexed in Scilit:
- Structure-based design, synthesis, and pharmacologic evaluation tf peptide RGS4 inhibitorsChemical Biology & Drug Design, 2008
- Multi-Tasking RGS Proteins in the HeartCirculation Research, 2005
- A Functional Polymorphism in RGS6 Modulates the Risk of Bladder CancerCancer Research, 2004
- RGS2 Binds Directly and Selectively to the M1 Muscarinic Acetylcholine Receptor Third Intracellular Loop to Modulate Gq/11α SignalingJournal of Biological Chemistry, 2004
- Regulators of G protein signalling: potential targets for treatment of allergic inflammatory diseases such as asthmaExpert Opinion on Therapeutic Targets, 2003
- Receptor-selective Effects of Endogenous RGS3 and RGS5 to Regulate Mitogen-activated Protein Kinase Activation in Rat Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2002
- Regulators of G-Protein signalling as new central nervous system drug targetsNature Reviews Drug Discovery, 2002
- A Point Mutation in Gαo and Gαi1Blocks Interaction with Regulator of G Protein Signaling ProteinsJournal of Biological Chemistry, 1998
- Carboxypeptidase E Activity Is Deficient in Mice with the fat MutationJournal of Biological Chemistry, 1996
- The GTPase-activating Protein RGS4 Stabilizes the Transition State for Nucleotide HydrolysisJournal of Biological Chemistry, 1996